This episode of Pharma Pulse dives into Cardinal Health’s acquisition of Solaris Health to strengthen specialty services, how ...

Eli Lilly (LLY) stock recovers as company executives seize a rare buying opportunity to make a series of insider purchases ...

Independent pharmacies are holding the line as reimbursement cuts, Rite Aid’s collapse and more push neighborhood health care to the brink.

AbbVie’s second quarter saw a significant positive market response, driven by robust sales from its immunology and ...

Thousands of Massachusetts biotech employees face job losses amid industry turmoil. Laid-off workers share their struggles ...

Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...

We are paying the highest drug prices in the world. Americans can’t continue to afford it,” CT Sen. Matt Lesser said.

Novo Nordisk has plummeted back to Earth after a stunning rise driven by Ozempic and Wegovy. Can the storied Danish pharma ...

Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...

Overweight patients waiting for operations could safely use a particular type of weight-loss treatment to reduce the risk of ...

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

Texas AG sues Eli Lilly for bribery related to prescribing GLP-1 meds for weight loss and diabetes, alleging unethical inducements to medical providers.